JAGX logo

Jaguar Health (JAGX) EBITDA

Annual EBITDA

-$33.13 M
+$249.00 K+0.75%

December 31, 2023

Summary

Performance

1-Year Change

+0.75%

3-Year Change

-15.29%

5-Year Change

-17.49%

15-Year Change

-127.93%

JAGX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.71%
JAGX annual EBITDA is higher than 39.71% of companies in Healthcare sector

High & Low

All-time High

-$8.32 M

3-Year Low

-$42.37 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
JAGX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
JAGX next annual earnings announcement is scheduled for Apr 1, 2025

OtherJAGXprofitabilitymetrics:

Annual Revenue

$9.76 M
JAGX annual revenue is $9.76 million

Annual Net Income

-$41.30 M
JAGX annual net profit is -$41.30 million

Annual EBIT

-$35.52 M
JAGX annual earnings before interest & taxes is -$35.52 million

Annual EPS

-$107.40
JAGX annual earnings per share is -$107.40

Quarterly EBITDA

-$6.67 M
-$28.00 K-0.42%

September 30, 2024

Summary

Performance

3-Month Change

-0.42%

1-Year Change

-0.42%

3-Year Change

+10.89%

5-Year Change

+10.89%

JAGX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.26%
JAGX quarterly EBITDA is higher than 43.26% of companies in Healthcare sector

High & Low

All-time High

-$1.84 M

3-Year Low

-$13.52 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
JAGX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
JAGX next earnings announcement is scheduled for Apr 1, 2025

OtherJAGXprofitabilitymetrics:

Quarterly Revenue

$3.11 M
JAGX quarterly revenue is $3.11 million

Quarterly Net Income

-$9.85 M
JAGX quarterly net profit is -$9.85 million

Quarterly EBIT

-$7.26 M
JAGX quarterly earnings before interest & taxes is -$7.26 million

Quarterly EPS

-$1.05
JAGX quarterly earnings per share is -$1.05

TTM EBITDA

-$29.64 M
+$1.50 M+4.80%

September 30, 2024

Summary

Performance

3-Month Change

+4.8%

1-Year Change

+4.8%

3-Year Change

+5.69%

5-Year Change

+5.69%

JAGX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.55%
JAGX TTM EBITDA is higher than 41.55% of companies in Healthcare sector

High & Low

All-time High

-$1.95 M

3-Year Low

-$46.20 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
JAGX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
JAGX next earnings announcement is scheduled for Apr 1, 2025

OtherJAGXprofitabilitymetrics:

TTM Revenue

$10.48 M
JAGX TTM revenue is $10.48 million

TTM Net Income

-$37.74 M
JAGX TTM net profit is -$37.74 million

TTM EBIT

-$32.00 M
JAGX TTM earnings before interest & taxes is -$32.00 million

TTM EPS

-$16.18
JAGX TTM earnings per share is -$16.18

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$33.13 M
JAGX annual EBITDA is -$33.13 million

Annual Net Income

-$41.30 M
JAGX annual net profit is -$41.30 million

Annual Interest Expense

$6.38 M
JAGX annual interest expense is $6.38 million

Annual Income Tax

$0.00
JAGX annual income tax is $0.00

Annual D&A

$2.39 M
JAGX annual depreciation & amortization is $2.39 million

JAGX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.8%-0.4%+4.8%
3 y3 years-15.3%+10.9%+5.7%
5 y5 years-17.5%+10.9%+5.7%

JAGX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+21.8%-33.4%+50.7%at high+35.8%
5 y5-year-15.3%+21.8%-33.4%+50.7%-11.6%+35.8%
alltimeall time-298.4%+21.8%-261.6%+50.7%-1417.7%+35.8%

Jaguar Health EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.67 M(+0.4%)
-$29.64 M(-4.8%)
Jun 2024
-
-$6.64 M(-18.5%)
-$31.14 M(-2.6%)
Mar 2024
-
-$8.15 M(-0.6%)
-$31.98 M(-4.5%)
Dec 2023
-$33.13 M(-0.7%)
-$8.19 M(+0.4%)
-$33.50 M(+10.6%)
Sep 2023
-
-$8.16 M(+9.1%)
-$30.30 M(-3.6%)
Jun 2023
-
-$7.48 M(-22.6%)
-$31.43 M(+4.2%)
Mar 2023
-
-$9.66 M(+93.5%)
-$30.16 M(-11.3%)
Dec 2022
-$33.38 M(-21.2%)
-$5.00 M(-46.2%)
-$34.01 M(-15.9%)
Sep 2022
-
-$9.29 M(+49.7%)
-$40.42 M(-0.9%)
Jun 2022
-
-$6.21 M(-54.1%)
-$40.77 M(-11.8%)
Mar 2022
-
-$13.52 M(+18.5%)
-$46.20 M(+9.1%)
Dec 2021
-$42.37 M(+47.4%)
-$11.41 M(+18.3%)
-$42.37 M(+12.2%)
Sep 2021
-
-$9.64 M(-17.2%)
-$37.76 M(+8.6%)
Jun 2021
-
-$11.64 M(+20.3%)
-$34.79 M(+11.1%)
Mar 2021
-
-$9.68 M(+42.2%)
-$31.30 M(+8.9%)
Dec 2020
-$28.74 M(-6.9%)
-$6.80 M(+2.1%)
-$28.74 M(+3.9%)
Sep 2020
-
-$6.66 M(-18.3%)
-$27.65 M(+4.1%)
Jun 2020
-
-$8.15 M(+14.6%)
-$26.55 M(-13.6%)
Mar 2020
-
-$7.11 M(+24.5%)
-$30.72 M(-0.5%)
Dec 2019
-$30.87 M
-$5.72 M(+2.6%)
-$30.87 M(-16.6%)
Sep 2019
-
-$5.57 M(-54.8%)
-$37.04 M(+1.7%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$12.32 M(+69.6%)
-$36.40 M(+18.6%)
Mar 2019
-
-$7.26 M(-38.9%)
-$30.70 M(+8.9%)
Dec 2018
-$28.20 M(+94.0%)
-$11.88 M(+140.7%)
-$28.20 M(+32.6%)
Sep 2018
-
-$4.94 M(-25.4%)
-$21.26 M(+7.8%)
Jun 2018
-
-$6.62 M(+38.8%)
-$19.72 M(+27.7%)
Mar 2018
-
-$4.77 M(-3.6%)
-$15.44 M(+6.2%)
Dec 2017
-$14.54 M(+7.4%)
-$4.94 M(+45.6%)
-$14.54 M(+12.8%)
Sep 2017
-
-$3.40 M(+45.4%)
-$12.89 M(+1.8%)
Jun 2017
-
-$2.34 M(-39.5%)
-$12.66 M(-7.8%)
Mar 2017
-
-$3.86 M(+17.0%)
-$13.72 M(+1.4%)
Dec 2016
-$13.54 M(+8.8%)
-$3.30 M(+4.3%)
-$13.54 M(-3.9%)
Sep 2016
-
-$3.16 M(-6.9%)
-$14.08 M(+3.0%)
Jun 2016
-
-$3.40 M(-7.6%)
-$13.67 M(+1.7%)
Mar 2016
-
-$3.68 M(-4.3%)
-$13.44 M(+8.0%)
Dec 2015
-$12.44 M(+49.6%)
-$3.84 M(+39.5%)
-$12.45 M(+19.1%)
Sep 2015
-
-$2.75 M(-13.1%)
-$10.45 M(+1.7%)
Jun 2015
-
-$3.17 M(+18.3%)
-$10.27 M(+13.6%)
Mar 2015
-
-$2.68 M(+45.3%)
-$9.04 M(+8.7%)
Dec 2014
-$8.32 M
-$1.84 M(-28.6%)
-$8.32 M(+28.5%)
Sep 2014
-
-$2.58 M(+33.4%)
-$6.47 M(+66.4%)
Jun 2014
-
-$1.94 M(-0.9%)
-$3.89 M(+99.1%)
Mar 2014
-
-$1.95 M
-$1.95 M

FAQ

  • What is Jaguar Health annual EBITDA?
  • What is the all time high annual EBITDA for Jaguar Health?
  • What is Jaguar Health annual EBITDA year-on-year change?
  • What is Jaguar Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Jaguar Health?
  • What is Jaguar Health quarterly EBITDA year-on-year change?
  • What is Jaguar Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Jaguar Health?
  • What is Jaguar Health TTM EBITDA year-on-year change?

What is Jaguar Health annual EBITDA?

The current annual EBITDA of JAGX is -$33.13 M

What is the all time high annual EBITDA for Jaguar Health?

Jaguar Health all-time high annual EBITDA is -$8.32 M

What is Jaguar Health annual EBITDA year-on-year change?

Over the past year, JAGX annual EBITDA has changed by +$249.00 K (+0.75%)

What is Jaguar Health quarterly EBITDA?

The current quarterly EBITDA of JAGX is -$6.67 M

What is the all time high quarterly EBITDA for Jaguar Health?

Jaguar Health all-time high quarterly EBITDA is -$1.84 M

What is Jaguar Health quarterly EBITDA year-on-year change?

Over the past year, JAGX quarterly EBITDA has changed by -$28.00 K (-0.42%)

What is Jaguar Health TTM EBITDA?

The current TTM EBITDA of JAGX is -$29.64 M

What is the all time high TTM EBITDA for Jaguar Health?

Jaguar Health all-time high TTM EBITDA is -$1.95 M

What is Jaguar Health TTM EBITDA year-on-year change?

Over the past year, JAGX TTM EBITDA has changed by +$1.50 M (+4.80%)